Physiogenex, a non clinical CRO dedidated to metabolic diseases, diabetes, insulin resistance,...
6
A leading preclinical CRO providing scientific expertise and outstanding research services on metabolic disorders and complications
-
Upload
physiogenex-preclinical-contract-research-cro -
Category
Healthcare
-
view
128 -
download
1
description
Physiogenex is a leading preclinical contrat research organization (CRO) specializing in metabolic disorders such as diabetes, obesity, liver diseases, dyslipidemia, atherosclerosis and diabetic nephropathy. Our combination of diet-induced animal models and state-of-the-art preclinical platform (in vivo, ex vivo and in vitro assays) makes Physiogenex your preferred research provider for first level phenotyping, screening and predictive proof of efficacy services in metabolic diseases and complications.
Transcript of Physiogenex, a non clinical CRO dedidated to metabolic diseases, diabetes, insulin resistance,...
- A leading preclinical CRO providing scientific expertise and outstanding research services on metabolic disorders and complications
- I Our fields of expertise
- I Our core competencies
- I A global vision A transversal approach of the metabolic syndrome
- Expertise and drug efficacy services for an integrated approach of metabolic diseases. More than just a CRO. I More than just a cro
- Bridge the gap between pre-clinical and clinical data with predictive and innovative in vivo validation. Physiogenex S.A.S. Prologue Biotech 516, rue Pierre et Marie Curie 31670 Labege - France +33 (0)5 61 28 70 40 Contact us [email protected] More on www.physiogenex.com
